Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
The variation of permanent prostate brachytherapy dosimetry as a function of seed localization uncertainty was investigated for I-125 implants with seed activities commonly employed in contemporary practice. Post-implant imaging and radiation dosimetry data from nine patients who underwent permanent prostate brachytherapy served as the source of clinical data for this simulation study. Gaussian noise with standard deviations ranging from 0.5 to 10 mm was applied to the seed coordinates for each patient dataset and 1000 simulations were performed at each noise level. Dose parameters, including D90, were computed for each case and compared with the actual dosimetry data. A total of 81 000 complete sets of post-brachytherapy dose volume statistics were computed. The results demonstrated that less than 5% deviation of prostate D90 can be expected when the seed localization uncertainty is 2 mm, whereas a seed localization uncertainty of 10 mm yielded an average decrease in D90 of 33 Gy. The mean normalized decrement in the prostate V100 was 10% at 5 mm uncertainty. Implants with greater seed number and larger prostate volume correlated with less sensitivity of D90 and V100 to seed localization uncertainty. Estimated target volume dose parameters tended to decrease with increasing seed localization uncertainty. The bladder V100 varied more significantly both in mean and standard deviation as compared to the urethra V100. A larger number of implanted seeds also correlated to less sensitivity of the bladder V100 to seed localization uncertainty. In contrast, the deviation of urethra V100 did not correlate with the number of implanted seeds or prostate volume.
Su
Yi
Y
Biomedical Imaging Resource, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Davis
Brian J
BJ
Furutani
Keith M
KM
Herman
Michael G
MG
Robb
Richard A
RA
D001918:Brachytherapy / Q000295:instrumentation* / Q000379:methods; D015331:Cohort Studies; D003198:Computer Simulation; D006801:Humans; D008297:Male; D016011:Normal Distribution; D011467:Prostate / Q000528:radiation effects; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011829:Radiation Dosage; D011874:Radiometry / Q000379:methods*; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted; D015203:Reproducibility of Results; D014521:Urethra / Q000528:radiation effects; D001743:Urinary Bladder / Q000528:radiation effects